Gary Shorter – Head, AI and Data Science, IQVIA Technologies
In the healthcare ecosystem, automation and data intelligence continue to gain momentum as artificial intelligence (AI) and machine learning (ML) are integrated to streamline and accelerate processes.
The clinical trial space is one area where…
Continue Reading
Sabrina Steffen, Head of Data Strategy and Innovation for Data Management at IQVIA
In drug development, there is a critical focus on protocol design, because it is a key component to running a successful clinical…
Continue Reading
Everybody loves to get and play with new toys. When we were children the toys were things like Barbies or Play-Doh. Now the toys we’re excited to get and play with are the emerging…
Continue Reading
The power and potential of artificial intelligence (AI) and machine learning (ML) in the healthcare industry are unparalleled. The use of automated technology systems like digital workflows, orchestration and storing of data digitally is…
Continue Reading
Prostate Cancer Research (PCR) has received sponsorship to support its first of its kind prostate cancer patient data platform and virtual registry.The project, which is supported by IQVIA and sponsored by Bayer and Advanced…
Continue Reading
TPG, a global alternative asset management firm, announced today that it has signed a definitive agreement to acquire Nextech, a leading provider of clinical and administrative healthcare technology solutions for specialty physician practices, from…
Continue Reading
Sonia Fischer, Customer Integrations Manager, IQVIA
In the age of biotechnology, biosample collection has become an essential part of medical research. Through this process, samples are taken from patients through a variety of sources, including…
Continue Reading
Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA
In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing…
Continue Reading
The following is a guest article by Yishai Knobel, CEO at RxWare
From April 2020 to August 2021, the healthcare solutions company Indegene looked at approximately 7.9 million emails sent by prescription drug companies across…
